Genprex, Inc.
GNPXdata completeness 63%10 fiscal years on fileData notes: no data for concept 'totalDebt'; no data for concept 'pretaxIncome'
Genprex, Inc. earns about -416% on equity, and has bought back 98% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $01 | $02 | $03 | $03 | — |
| Net income | −$20.7M4 | −$23.7M5 | −$30.9M6 | −$21.1M7 | −$16.2M7 |
| Operating cash flow | −$14.3M8 | −$17.6M9 | −$24.7M10 | −$17.9M11 | −$15.3M11 |
| Capital expenditure | $31,70012 | $012 | — | — | — |
| Free cash flow (derived) | −$14.3M8 | −$17.6M9 | — | — | — |
| Total debt | — | — | — | — | — |
| Cash & equivalents | — | $21M13 | $6.74M14 | $1.6M15 | $7.83M15 |
| Diluted shares | 47.1M | 1.2M | 1.4M | 80,139 | 932,730 |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $85.36 of net worth that earned you −$173.99 last year.
It earned an average -416% on equity over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 98% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001437749-23-008847 (Revenues)
- 10-K · period ending 2022-12-31 · accession 0001437749-24-010426 (Revenues)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-010311 (Revenues)
- 10-K · period ending 2021-12-31 · accession 0001437749-23-008847 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001437749-24-010426 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-010311 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-010346 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001437749-23-008847 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001437749-24-010426 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-010311 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-010346 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001437749-23-008847 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001437749-24-010426 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-010311 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-010346 (CashAndCashEquivalentsAtCarryingValue)